Medicare drug pricing is changing in 2027, and some of the headlines could easily confuse clients.
CMS has published negotiated prices for 15 Medicare Part D drugs that take effect January 1, 2027. Some of the reductions are significant, including several widely used medications.
But there is one important distinction agents need to communicate:
The negotiated price is not automatically the client’s pharmacy copay.
A client’s actual prescription costs can still depend on their plan, formulary, deductible, drug tier, pharmacy, and other coverage factors.
In Episode 26 of The Insurance Producers Guild, we break down the 2027 Medicare drug price changes and explain what agents should—and should not—tell clients.
Listen here:
https://www.youtube.com/watch?v=6NDeZdBSZvc
CMS selected 15 Part D drugs for negotiated pricing beginning in 2027.
According to CMS, approximately 5.3 million Medicare Part D enrollees used these drugs in 2024, and the agency estimates about $685 million in beneficiary out-of-pocket savings in 2027 under the standard benefit design.
One of the most visible examples is Ozempic, Rybelsus, and Wegovy.
CMS lists:
That is a substantial reduction—but agents should not present $274 as the amount every client will pay.
The simplest message is:
“Medicare has negotiated new prices for several drugs in 2027, but your actual pharmacy cost will still depend on your plan. We should review your medications and coverage before AEP.”
That keeps expectations realistic while creating a natural reason for a plan review.
Agents should avoid focusing on one high-profile drug alone.
A client’s total prescription costs can be affected by:
The best plan for one prescription may not be the best plan for the client’s complete medication list.
Agents can begin now by identifying clients who use the affected medications.
Consider:
The goal is simple: help clients understand what the new pricing actually means for their coverage.
Medicare changes create questions—and independent agents play an important role in helping clients understand their options.
PSM Brokerage supports agents with Medicare carrier access, enrollment technology, marketing resources, compliance support, contracting assistance, and experienced one-on-one guidance.
Explore Medicare solutions:
https://www.psmbrokerage.com/product-portfolio/medicare-solutions
Prepare for AEP:
https://www.psmbrokerage.com/aep-preparation-guide
CMS — Medicare Drug Price Negotiation Program
https://www.cms.gov/initiatives/medicare-prescription-drug-affordability/overview/medicare-drug-price-negotiation-program/selected-drugs-negotiated-prices
The Insurance Producers Guild — Episode 26
https://www.youtube.com/watch?v=6NDeZdBSZvc